Boosting the Potency of T-cell Therapies.

Researchers in the adoptive T-cell therapy field are continuing to refine the ways in which the specificity of these immune cells can be redirected toward tumors. They've found that selecting the most persistent, proliferative T cells-and genetically manipulating only these defined subsets-ensures a potent therapeutic product that's effective even at minuscule doses.